Commensal bacteria promote migration of mast cells into the intestine

Immunobiology

Volumn 216, Issue 6, 2011, Pages 692-697

  Kunii, Junichi ^a   Takahashi, Kyoko ^a   Kasakura, Kazumi ^a   Tsuda, Masato ^a   Nakano, Kou ^a   Hosono, Akira ^a   Kaminogawa, Shuichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Commensal bacteria; CXCR2 ligand; Intestine; Mast cell; Migration; Toll like receptor

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL FUNCTION; CELL HOMING; CELL MIGRATION; CELLULAR DISTRIBUTION; COMMENSAL; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LAMINA PROPRIA; LEUKOCYTE COUNT; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMALL INTESTINE; UPREGULATION;

ANIMALS; BACTERIA; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; INTESTINES; LIGANDS; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, INTERLEUKIN-8B;

EID: 79955527625     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.10.007     Document Type: Article

References (29)

1. Abdel-Majid R.M., Marshall J.S. Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J. Immunol. 2004, 172:1227-1236.
2. Abonia J.P., Austen K.F., Rollins B.J., Joshi S.K., Flavell R.A., Kuziel W.A., Koni P.A., Gurish M.F. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 2005, 105:4308-4313.
3. Applequist S.E., Wallin R.P., Ljunggren H.G. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int. Immunol. 2002, 14:1065-1074.
4. Bischoff S.C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 2007, 7:93-104.
5. Bischoff S.C., Wedemeyer J., Herrmann A., Meier P.N., Trautwein C., Cetin Y., Maschek H., Stolte M., Gebel M., Manns M.P. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996, 28:1-13.
6. Björkstén B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001, 108:516-520.
7. Chen J.J., Li Z., Pan H., Murphy D.L., Tamir H., Koepsell H., Gershon M.D. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J. Neurosci. 2001, 21:6348-6361.
8. Dawicki W., Marshall J.S. New and emerging roles for mast cells in host defense. Curr. Opin. Immunol. 2007, 19:31-38.
9. Féger F., Varadaradjalou S., Gao Z., Abraham S.N., Arock M. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 2002, 23:151-157.
10. Fehrenbach K., Port F., Grochowy G., Kalis C., Bessler W., Galanos C., Krystal G., Freudenberg M., Huber M. Stimulation of mast cells via Fce{open}RI and TLR2: the type of ligand determines the outcome. Mol. Immunol. 2007, 44:2087-2094.
11. Furuta T., Imajo-Ohmi S., Fukuda H., Kano S., Miyake K., Watanabe N. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur. J. Immunol. 2008, 38:1341-1350.
12. Galli S.J., Maurer M., Lentz C.S. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 1999, 11:53-59.
13. Gibson D.L., Ma C., Bergstrom K.S., Huang J.T., Man C., Vallance B.A. MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell. Microbiol. 2008, 10:618-631.
14. Groschwitz K.R., Ahrens R., Osterfeld H., Gurish M.F., Han X., Abrink M., Finkelman F.D., Pejler G., Hogan S.P. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:22381-22386.
15. Gurish M.F., Tao H., Abonia J.P., Arya A., Friend D.S., Parker C.M., Austen K.F. Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing. J. Exp. Med. 2001, 194:1243-1252.
16. Hu Z.Q., Zhao W.H., Shimamura T. Regulation of mast cell development by inflammatory factors. Curr. Med. Chem. 2007, 14:3044-3050.
17. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001, 107:129-134.
18. Kasakura K., Takahashi K., Aizawa T., Hosono A., Kaminogawa S. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells. Int. Arch. Allergy Immunol. 2009, 150:359-369.
19. Kulka M., Alexopoulou L., Flavell R.A., Metcalfe D.D. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 2004, 114:174-182.
20. Kulka M., Metcalfe D.D. TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol. Immunol. 2006, 43:1579-1586.
21. Magerl M., Lammel V., Siebenhaar F., Zuberbier T., Metz M., Maurer M. Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp. Dermatol. 2008, 17:427-435.
22. Mah K.W., Björkstén B., Lee B.W., van Bever H.P., Shek L.P., Tan T.N., Lee Y.K., Chua K.Y. Distinct pattern of commensal gut microbiota in toddlers with eczema. Int. Arch. Allergy Immunol. 2006, 140:157-163.
23. Marshall J.S. Mast-cell response to pathogens. Nat. Rev. Immunol. 2004, 4:787-799.
24. Penders J., Thijs C., van den Brandt P.A., Kummeling I., Snijders B., Stelma F., Adams H., van Ree R., Stobberingh E.E. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study. Gut 2007, 56:661-667.
25. Qiao H., Andrade M.V., Lisboa F.A., Morgan K., Beaven M.A. Fce{open}RI and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006, 107:610-618.
26. Sepp E., Julge K., Mikelsaar M., Björkstén B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin. Exp. Allergy 2005, 35:1141-1146.
27. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C., Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 2001, 167:2250-2256.
28. Varadaradjalou S., Féger F., Thieblemont N., Hamouda N.B., Pleau J.M., Dy M., Arock M. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 2003, 33:899-906.
29. Yoshioka M., Fukunishi N., Iriguchi S., Ohsaki K., Yamanobe H., Inukai A., Kurihara D., Imajo N., Yasui Y., Matsui N., Tsujita T., Ishii A., Seya T., Takahama M., Akagi M. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. J. Allergy Clin. Immunol. 2007, 120:452-456.